Homozygous deletion of CDKN2A/B is uniformly associated with a worse prognosis in GBM and IDH-mutant astrocytoma, which may partially explain the aggressive behavior of HGAP [5, 8]. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).